VHL p.Pro103=
c.309T>C · rs1262511541 · VCV1077591
Benign/Likely benign
Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Conditions
3
hereditary neoplastic syndrome
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -3.4 | GERP -2.6 |
| Overall | ||
| CADD | 7.055 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
8.48e-05%
European (non-Finnish) · 1/1,179,452 alleles
Overall
6.26e-05%
1/1,598,712 alleles · very rare
exomes 1/1,446,498 · genomes 0/152,214 · joint denominator
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- VHL
- Protein
- p.Pro103=
- Coding
- c.309T>C
- MANE Select
- NM_000551
- dbSNP
- rs1262511541
- Type
- single nucleotide variant
- Location
- chr3:10142156 (GRCh38)
- Gene constraint
- LOEUF 0.987 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 85.45 · 143 PDB
- Residue 103
- the 'involved in binding to cct complex' region
Similar variants
- VHL p.Pro103Ala Conflicting classifications of pathogenicity ★ ⚠ same residue
- VHL p.Pro103Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- VHL p.Pro103Ser Uncertain significance ★ ⚠ same residue
- VHL p.Pro103fs Pathogenic ★ same residue
- VHL p.Arg64Pro Pathogenic ★★★ same condition
- VHL p.Asn78Ser Pathogenic ★★★ ⚠ same condition
- VHL p.Glu70Ter Pathogenic ★★★ same condition
- VHL p.Pro86Leu Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/vhl-p-pro103 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown